Hasil Pencarian - Miso Park
- Menampilkan 1 - 15 hasil dari 15
-
1
Microbial Biosensors: Engineered Microorganisms as the Sensing Machinery oleh Miso Park, Shen-Long Tsai, Wilfred Chen
Diterbitkan 2013-05-01
Artikel -
2
-
3
Positional assembly of enzymes on bacterial outer membrane vesicles for cascade reactions. oleh Miso Park, Qing Sun, Fang Liu, Matthew P DeLisa, Wilfred Chen
Diterbitkan 2014-01-01
Artikel -
4
-
5
-
6
-
7
Induction of islet autoimmunity to defective ribosomal product of the insulin gene as neoantigen after anti-cancer immunotherapy leading to autoimmune diabetes oleh Rene van Tienhoven, Rene van Tienhoven, Diahann T. S. L. Jansen, Miso Park, John C. Williams, James Larkin, Sergio A. Quezada, Bart O. Roep
Diterbitkan 2024-03-01
Artikel -
8
Antibody-based redirection of universal Fabrack-CAR T cells selectively kill antigen bearing tumor cells oleh Christine Brown, Wen-Chung Chang, Renate Starr, Brenda Aguilar, Kurt Jenkins, Miso Park, Cheng-Fu Kuo, Yi-Chiu Kuo, Alfur Fu-Hsin Hung, Jonathan Hibbard, John C Williams
Diterbitkan 2022-06-01
Artikel -
9
TYRO3 blockade enhances anti-PD-1 therapy response by modulating expression of CCN1 in tumor microenvironment oleh Miso Park, Da-Sol Kuen, Keon Wook Kang, Yeonseok Chung, Jaewoo Park, Munkyung Choi, Yeonji Kim, Eun Chae Roh, Yong June Choi, Yoon Gyoon Kim, Sung Yun Cho
Diterbitkan 2023-01-01
Artikel -
10
PLM-101 is a novel and potent FLT3/RET inhibitor with less adverse effects in the treatment of acute myeloid leukemia oleh Yong June Choi, Jaewoo Park, Hyoyi Choi, Su-Jin Oh, Jin-Hee Park, Miso Park, Ji Won Kim, Yoon-Gyoon Kim, Yong-Chul Kim, Myung Jin Kim, Keon Wook Kang
Diterbitkan 2023-09-01
Artikel -
11
587 Tumor-activated Fc-engineered anti-CTLA-4 monoclonal antibody, XTX101, demonstrates tumor-selective PD and efficacy in preclinical models oleh John Williams, Wilson Guzman, Minjie Zhang, Parker Johnson, Megan McLaughlin, Kurt Jenkins, Caitlin O’Toole, Magali Pederzoli-Ribeil, Margaret Karow, Ronan O’Hagan, Jennifer O’Neil, Ugur Eskiocak, Miso Park, Timothy Clackson
Diterbitkan 2020-11-01Artikel -
12
Therapeutic strategy using novel RET/YES1 dual-target inhibitor in lung cancer oleh Yong June Choi, Munkyung Choi, Jaewoo Park, Miso Park, Myung Jun Kim, Jae-sun Lee, Su-jin Oh, Young Joo Lee, Wan Seob Shim, Ji Won Kim, Myung Jin Kim, Yong-Chul Kim, Keon Wook Kang
Diterbitkan 2024-02-01
Artikel -
13
Tonic type 2 immunity is a critical tissue checkpoint controlling autoimmunity in the skin oleh Jeong-Eun Lee, Mina Kim, Sotaro Ochiai, Sung-Hee Kim, Hyeonuk Yeo, Jahyun Bok, Jiyeon Kim, Miso Park, Daehong Kim, Olivier Lamiable, Myunggyo Lee, Min-Ju Kim, Hye Young Kim, Franca Ronchese, Sung Won Kwon, Haeseung Lee, Tae-Gyun Kim, Yeonseok Chung
Diterbitkan 2024-07-01
Artikel -
14
XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4 monoclonal antibody, demonstrates tumor-growth inhibition and tumor-selective pharmacodynamics in mouse models of cancer oleh Zhen Liu, Wilson Guzman, Parker Johnson, Megan McLaughlin, Caitlin O’Toole, Magali Pederzoli-Ribeil, Huawei Qiu, Margaret Karow, Tim Clackson, Jennifer O’Neil, Ugur Eskiocak, Miso Park, Benjamin Nicholson, John C Williams, Kurt A Jenkins, Deborah Moore-Lai, Veronica Flesch, Ronan C O’Hagan, Ulrich Rodeck
Diterbitkan 2023-12-01
Artikel -
15
IL1RAP-specific T cell engager depletes acute myeloid leukemia stem cells oleh Yi Zhang, Miso Park, Lucy Y. Ghoda, Dandan Zhao, Melissa Valerio, Ebtesam Nafie, Asaul Gonzalez, Kevin Ly, Bea Parcutela, Hyeran Choi, Xubo Gong, Fang Chen, Kaito Harada, Zhenhua Chen, Le Xuan Truong Nguyen, Flavia Pichiorri, Jianjun Chen, Joo Song, Stephen J. Forman, Idoroenyi Amanam, Bin Zhang, Jie Jin, John C. Williams, Guido Marcucci
Diterbitkan 2024-08-01
Artikel